Treatment Does Little to Prevent Hypertension and Microalbuminuria in Children with Diabetes

Published Online: Monday, July 22, 2013
Follow Pharmacy_Times:
Children with type 2 diabetes continue to develop hypertension and microalbuminuria at fast rates, regardless of treatment, according to the results of a study published in the June 2013 issue of Diabetes Care.
 
The study included nearly 700 overweight children from the TODAY clinical trial, an ongoing study on treatment of type 2 diabetes in children and adolescents. Children in the current study were aged between 10 and 17 and had been diagnosed with diabetes for less than 2 years. The participating children were randomly assigned to receive metformin, metformin plus rosiglitazone, or metformin plus lifestyle intervention.
 
At the start of the study, 11.6% of participants had hypertension. By the end of the study (average follow-up of 3.9 years), 33.8% had hypertension. In addition, the rate of microalbuminuria among participants increased from 6.3% at baseline to 16.6% at the end of the study. The researchers also observed that boys and those with higher BMIs were at significantly increased risk for hypertension. Risk of microalbuminuria was associated with poor glycemic control, but not with a particular gender or ethnicity.
 
The authors note that the progression of hypertension and microalbuminuria observed in children was faster than that typically seen in adults and stress the importance of obesity prevention starting at young ages.
 
 


Related Articles
The FDA today approved a new 200 unit/mL formulation of Lilly’s Humalog KwikPen for patients with type 1 and type 2 diabetes.
Noting national drug shortages often disproportionately affect pediatric patients, the Pediatric Pharmacy Advocacy Group (PPAG) is encouraging the FDA to include child-specific considerations in its policies for preventing and mitigating drug shortages.
Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses the role pharmacists can play when helping clinicians overcome barriers to initiating insulin use.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$